T. Borland

A combinatorial library of lipid-like materials for delivery of RNAi therapeutics

Robert Langer, Valentina Busini, Andreas Zumbuehl, 2008, Nature Biotechnology.

Rational design of cationic lipids for siRNA delivery

K. G. Rajeev, M. Manoharan, A. Akinc, 2010, Nature Biotechnology.

Safety and efficacy of RNAi therapy for transthyretin amyloidosis.

B. Bettencourt, P. Lozeron, P. Hawkins, 2013, The New England journal of medicine.

CRISPR/Cas9 Genome Editing to Treat Sickle Cell Disease and B-Thalassemia: Re-Creating Genetic Variants to Upregulate Fetal Hemoglobin Appear Well-Tolerated, Effective and Durable.

Chad A. Cowan, A. Kernytsky, Angela Yen, 2017 .

RNA Interference-Mediated Silencing of the Respiratory Syncytial Virus Nucleocapsid Defines a Potent Antiviral Strategy

Svetlana Shulga Morskaya, M. Manoharan, M. Van Ranst, 2009, Antimicrobial Agents and Chemotherapy.

Preclinical evaluation of RNAi as a treatment for transthyretin-mediated amyloidosis

S. Milstein, K. G. Rajeev, M. Manoharan, 2016, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.